These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8932693)

  • 1. A feasibility study of the multiple-peak approach for pharmacokinetic screening: population-based investigation of valproic acid relative clearance using routine clinical pharmacokinetic data.
    Yukawa E
    J Pharm Pharmacol; 1995 Dec; 47(12A):1048-52. PubMed ID: 8932693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1997 Aug; 49(8):751-6. PubMed ID: 9379350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data.
    Yukawa E; Aoyama T
    J Clin Pharmacol; 1996 Aug; 36(8):752-9. PubMed ID: 8877681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data.
    Blanco-Serrano B; Otero MJ; Santos-Buelga D; García-Sánchez MJ; Serrano J; Domínguez-Gil A
    Biopharm Drug Dispos; 1999 Jul; 20(5):233-40. PubMed ID: 10594867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepidemiologic investigation of a clonazepam-valproic acid interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Nonaka T; Yukawa M; Higuchi S; Kuroda T; Goto Y
    J Clin Pharm Ther; 2003 Dec; 28(6):497-504. PubMed ID: 14651674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.
    EL Desoky ES; Fuseau E; EL Din Amry S; Cosson V
    Eur J Clin Pharmacol; 2004 Jan; 59(11):783-90. PubMed ID: 14673555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics.
    Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Dec; 37(12):1160-7. PubMed ID: 9506012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic modelling of valproate in epileptic patients].
    Jakovljević MB; Janković SM; Todorović N; Milovanović JR; Janković S
    Med Pregl; 2010; 63(5-6):349-55. PubMed ID: 21186545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of apparent clearance of valproic acid in adult Saudi patients.
    Alqahtani S; Alandas N; Alsultan A
    Int J Clin Pharm; 2019 Aug; 41(4):1056-1061. PubMed ID: 31222537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of intravenous valproic acid in Korean patients.
    Park HM; Kang SS; Lee YB; Shin DJ; Kim ON; Lee SB; Yim DS
    J Clin Pharm Ther; 2002 Dec; 27(6):419-25. PubMed ID: 12472981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens.
    Methaneethorn J
    Clin Ther; 2017 Jun; 39(6):1171-1181. PubMed ID: 28483293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
    Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS
    Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a quick modeling program generating clearance estimates at steady state for routine therapeutic drug monitoring.
    el Battah A; Beglia S; Alric R
    Ther Drug Monit; 1995 Aug; 17(4):348-55. PubMed ID: 7482688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoepidemiologic investigation of clonazepam relative clearance by mixed-effect modeling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Satou M; Nonaka T; Yukawa M; Ohdo S; Higuchi S; Kuroda T; Goto Y
    J Clin Pharmacol; 2002 Jan; 42(1):81-8. PubMed ID: 11808828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.